Hypertension in patients with diabetes mellitus

Jay S Skyler, Jennifer B Marks, Neil Schneiderman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Diabetes mellitus and hypertension each confer increased cardiovascular risk. That risk is much greater when the diseases coexist and is further magnified by their frequent association with dyslipidemia and central obesity. Insulin resistance appears to be an important common component to these four entities, whether or not the relationship is truly cause and effect. Increased renal tubule absorption of sodium and increased sympathetic nervous system stimulation from insulin have been said to be the mechanisms by which elevated levels of insulin cause hypertension. However, animal experiments suggest that these are short-term effects only and that long-term insulin may actually increase peripheral blood flow and reduce blood pressure. Experiments in humans suggest that the insulin resistant state in obese patients and type II diabetics is associated with a decrease of the usual vasodilatory effect of insulin. Antihypertensive drugs have differing effects on insulin resistance. Angiotensin converting enzyme inhibitors, α-adrenergic blockers, and dihydropyridines appear to improve insulin sensitivity. Other calcium channel blockers appear to be neutral, as is furosemide. Thiazide diuretics, spironolactone, and β-adrenergic blockers impair insulin sensitivity. The drugs that increase insulin sensitivity also tend to improve dyslipidemia or remain lipid neutral. In contrast, those drugs that tend to impair insulin sensitivity also tend to worsen dyslipidemia.

Original languageEnglish
JournalAmerican Journal of Hypertension
Volume8
Issue number12 PART 2
DOIs
StatePublished - Jan 1 1995

Fingerprint

Insulin Resistance
Diabetes Mellitus
Hypertension
Insulin
Dyslipidemias
Adrenergic Antagonists
Dihydropyridines
Sodium Chloride Symporter Inhibitors
Spironolactone
Abdominal Obesity
Sympathetic Nervous System
Furosemide
Calcium Channel Blockers
Angiotensin-Converting Enzyme Inhibitors
Pharmaceutical Preparations
Antihypertensive Agents
Sodium
Blood Pressure
Lipids

Keywords

  • cardiovascular risk
  • diabetes mellitus
  • dyslipidemia
  • hypertension
  • Insulin sensitivity
  • Syndrome X

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Hypertension in patients with diabetes mellitus. / Skyler, Jay S; Marks, Jennifer B; Schneiderman, Neil.

In: American Journal of Hypertension, Vol. 8, No. 12 PART 2, 01.01.1995.

Research output: Contribution to journalArticle

@article{eb94052be030438186b2d719a9d417cd,
title = "Hypertension in patients with diabetes mellitus",
abstract = "Diabetes mellitus and hypertension each confer increased cardiovascular risk. That risk is much greater when the diseases coexist and is further magnified by their frequent association with dyslipidemia and central obesity. Insulin resistance appears to be an important common component to these four entities, whether or not the relationship is truly cause and effect. Increased renal tubule absorption of sodium and increased sympathetic nervous system stimulation from insulin have been said to be the mechanisms by which elevated levels of insulin cause hypertension. However, animal experiments suggest that these are short-term effects only and that long-term insulin may actually increase peripheral blood flow and reduce blood pressure. Experiments in humans suggest that the insulin resistant state in obese patients and type II diabetics is associated with a decrease of the usual vasodilatory effect of insulin. Antihypertensive drugs have differing effects on insulin resistance. Angiotensin converting enzyme inhibitors, α-adrenergic blockers, and dihydropyridines appear to improve insulin sensitivity. Other calcium channel blockers appear to be neutral, as is furosemide. Thiazide diuretics, spironolactone, and β-adrenergic blockers impair insulin sensitivity. The drugs that increase insulin sensitivity also tend to improve dyslipidemia or remain lipid neutral. In contrast, those drugs that tend to impair insulin sensitivity also tend to worsen dyslipidemia.",
keywords = "cardiovascular risk, diabetes mellitus, dyslipidemia, hypertension, Insulin sensitivity, Syndrome X",
author = "Skyler, {Jay S} and Marks, {Jennifer B} and Neil Schneiderman",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0895-7061(95)00307-X",
language = "English",
volume = "8",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "12 PART 2",

}

TY - JOUR

T1 - Hypertension in patients with diabetes mellitus

AU - Skyler, Jay S

AU - Marks, Jennifer B

AU - Schneiderman, Neil

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Diabetes mellitus and hypertension each confer increased cardiovascular risk. That risk is much greater when the diseases coexist and is further magnified by their frequent association with dyslipidemia and central obesity. Insulin resistance appears to be an important common component to these four entities, whether or not the relationship is truly cause and effect. Increased renal tubule absorption of sodium and increased sympathetic nervous system stimulation from insulin have been said to be the mechanisms by which elevated levels of insulin cause hypertension. However, animal experiments suggest that these are short-term effects only and that long-term insulin may actually increase peripheral blood flow and reduce blood pressure. Experiments in humans suggest that the insulin resistant state in obese patients and type II diabetics is associated with a decrease of the usual vasodilatory effect of insulin. Antihypertensive drugs have differing effects on insulin resistance. Angiotensin converting enzyme inhibitors, α-adrenergic blockers, and dihydropyridines appear to improve insulin sensitivity. Other calcium channel blockers appear to be neutral, as is furosemide. Thiazide diuretics, spironolactone, and β-adrenergic blockers impair insulin sensitivity. The drugs that increase insulin sensitivity also tend to improve dyslipidemia or remain lipid neutral. In contrast, those drugs that tend to impair insulin sensitivity also tend to worsen dyslipidemia.

AB - Diabetes mellitus and hypertension each confer increased cardiovascular risk. That risk is much greater when the diseases coexist and is further magnified by their frequent association with dyslipidemia and central obesity. Insulin resistance appears to be an important common component to these four entities, whether or not the relationship is truly cause and effect. Increased renal tubule absorption of sodium and increased sympathetic nervous system stimulation from insulin have been said to be the mechanisms by which elevated levels of insulin cause hypertension. However, animal experiments suggest that these are short-term effects only and that long-term insulin may actually increase peripheral blood flow and reduce blood pressure. Experiments in humans suggest that the insulin resistant state in obese patients and type II diabetics is associated with a decrease of the usual vasodilatory effect of insulin. Antihypertensive drugs have differing effects on insulin resistance. Angiotensin converting enzyme inhibitors, α-adrenergic blockers, and dihydropyridines appear to improve insulin sensitivity. Other calcium channel blockers appear to be neutral, as is furosemide. Thiazide diuretics, spironolactone, and β-adrenergic blockers impair insulin sensitivity. The drugs that increase insulin sensitivity also tend to improve dyslipidemia or remain lipid neutral. In contrast, those drugs that tend to impair insulin sensitivity also tend to worsen dyslipidemia.

KW - cardiovascular risk

KW - diabetes mellitus

KW - dyslipidemia

KW - hypertension

KW - Insulin sensitivity

KW - Syndrome X

UR - http://www.scopus.com/inward/record.url?scp=0029451989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029451989&partnerID=8YFLogxK

U2 - 10.1016/0895-7061(95)00307-X

DO - 10.1016/0895-7061(95)00307-X

M3 - Article

C2 - 8845091

AN - SCOPUS:0029451989

VL - 8

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 12 PART 2

ER -